Medexus Pharmaceuticals Inc.

MDP.TOTSXHealthcare● Active

$3.95

+$0.04(+1.02%)

Market Cap$127586501

P/E Ratio—

52W High$4.17

52W Low$2.47

Avg Volume51K

Open$3.86

Beta1.84

Net Income Financials Revenue

Medexus Pharmaceuticals Inc. (MDP.TO) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

MDP.TO · net income · updated Jun 8, 2026

Core profitability metrics

MDP.TO · net income · margin · TTM · CAGR

Net income was $2.2M for FY2025 (fiscal year ending 2025-03-31), up 1150.0% year-over-year. Net profit margin was 2.1%. Based on available data, Medexus Pharmaceuticals Inc. has been profitable since at least 2023.

FY2025 Net Income$2.2M▲ +1150.0% YoY

Trailing 12M (TTM)−$272,000trailing 4 quarters sum

Net Profit Margin2.1%$2.2M ÷ $108.3M

YoY Change+1150.0%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2023

▸ FMP /income-statement · Annual · MDP.TO net income history · MDP.TO profit margin

Annual net income data

MDP.TO · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$2.2M▲ +1150.0%2.1%$108.3M

FY2024Loss−$214,000▼ 117.5%-0.2%$113.1M

FY2023★ First Profit$1.2M▲ +142.4%1.1%$108.1M

FY2022Loss−$2.9M▲ +89.8%-3.8%$76.7M

FY2021Loss−$28.3M▼ 501.2%-35.5%$79.7M

Net income vs peers (Healthcare)

MDP.TO vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Medexus Pharmaceuticals Inc.YOU

MDP.TO

$2.2M+1150.0%2.1%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Medexus Pharmaceuticals Inc. (MDP.TO) reported net income of $2.2M for FY2025 (fiscal year ending 2025-03-31), up 1150.0% year-over-year. The net profit margin was 2.1% — meaning the company kept $0.02 of every dollar of revenue as profit.

Based on available data, Medexus Pharmaceuticals Inc. has been profitable since at least 2023. Net income reached a peak of $2.2M in FY2025. Data available for 14 fiscal years.

Medexus Pharmaceuticals Inc.'s net profit margin was 2.1% for FY2025, based on the latest annual results.

Investors sometimes search for "Medexus Pharmaceuticals Inc. net worth" — the company's market capitalization is a separate figure from MDP.TO net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

MDP.TO net income · 5 questions

Medexus Pharmaceuticals Inc. is profitable. The company reported net income of $2.2M for FY2025, a net profit margin of 2.1%. Net income was up 1150.0% year-over-year. Based on available data, Medexus Pharmaceuticals Inc. has been profitable since at least 2023.

is MDP.TO profitabledoes MDP.TO make a profitMDP.TO profitabilityMDP.TO profitable company

▸ Source: FMP /income-statement · GAAP · Medexus Pharmaceuticals Inc. · Medexus Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026